Are  	Are  	 VBP	O
low  	low  	 JJ	O
levels  	levels  	 NNS	O
of  	of  	 IN	O
25-hydroxyvitamin  	25-hydroxyvitamin  	 NNP	O
D  	D  	 NNP	O
a  	a  	 DT	O
risk  	risk  	 NN	B-NP
factor  	factor  	 NN	I-NP
for  	for  	 IN	I-NP
cardiovascular  	cardiovascular  	 JJ	I-NP
diseases  	diseases  	 NNS	I-NP
or  	or  	 CC	O
malignancies  	malignancies  	 NN	O
in  	in  	 IN	O
renal  	renal  	 JJ	B-NP
transplantation 	transplantation 	 NN	I-NP
?  	?  	 .	O
Observational  	Observational  	 JJ	B-NP
studies  	studies  	 NNS	I-NP
in  	in  	 IN	O
healthy  	healthy  	 JJ	O
people  	people  	 NNS	O
suggest  	suggest  	 VBP	O
an  	an  	 DT	O
inverse  	inverse  	 JJ	B-NP
relationship  	relationship  	 NN	I-NP
between  	between  	 IN	O
25-hydroxy-vitamin  	25-hydroxy-vitamin  	 NNP	O
D  	D  	 NNP	O
( 	( 	 -LRB-	O
25 	25 	 CD	B-NP
( 	( 	 -LRB-	I-NP
OH 	OH 	 NNP	I-NP
) 	) 	 -RRB-	I-NP
D  	D  	 NNP	I-NP
levels 	levels 	 NNS	O
)  	)  	 -RRB-	O
and  	and  	 CC	O
cardiovascular  	cardiovascular  	 JJ	B-NP
diseases  	diseases  	 NNS	I-NP
and  	and  	 CC	O
malignancies 	malignancies 	 NN	O
.  	.  	 .	O
We  	We  	 PRP	O
performed  	performed  	 VBD	O
an  	an  	 DT	O
observational  	observational  	 JJ	B-NP
prospective  	prospective  	 JJ	I-NP
study  	study  	 NN	I-NP
in  	in  	 IN	O
renal  	renal  	 JJ	B-NP
transplant  	transplant  	 NN	I-NP
recipients  	recipients  	 NNS	I-NP
to  	to  	 TO	O
investigate  	investigate  	 VB	O
the  	the  	 DT	O
effects  	effects  	 NNS	O
of  	of  	 IN	O
vitamin  	vitamin  	 JJ	O
D  	D  	 NNP	O
deficiency  	deficiency  	 NN	O
on  	on  	 IN	O
cardiovascular  	cardiovascular  	 JJ	O
and  	and  	 CC	O
malignancy  	malignancy  	 JJ	B-NP
risks 	risks 	 NNS	I-NP
.  	.  	 .	O
From  	From  	 IN	O
389  	389  	 CD	O
renal  	renal  	 JJ	B-NP
transplant  	transplant  	 NN	I-NP
recipients 	recipients 	 NNS	I-NP
,  	,  	 ,	O
331  	331  	 CD	O
with  	with  	 IN	O
a  	a  	 DT	O
functioning  	functioning  	 JJ	O
graft  	graft  	 NN	O
at  	at  	 IN	O
12  	12  	 CD	O
months  	months  	 NNS	O
were  	were  	 VBD	O
included  	included  	 VBN	O
in  	in  	 IN	O
the  	the  	 DT	O
study 	study 	 NN	O
.  	.  	 .	O
Mineral  	Mineral  	 JJ	B-NP
metabolism  	metabolism  	 NN	I-NP
parameters  	parameters  	 NNS	I-NP
were  	were  	 VBD	O
measured  	measured  	 VBN	O
at  	at  	 IN	O
1 	1 	 CD	O
,  	,  	 ,	O
3 	3 	 CD	O
,  	,  	 ,	O
4  	4  	 CD	O
and  	and  	 CC	O
12  	12  	 CD	O
months 	months 	 NNS	O
.  	.  	 .	O
Information  	Information  	 NN	O
regarding  	regarding  	 VBG	O
the  	the  	 DT	O
cardiovascular  	cardiovascular  	 JJ	B-NP
events  	events  	 NNS	I-NP
and  	and  	 CC	O
malignancies  	malignancies  	 NNS	O
were  	were  	 VBD	O
collected  	collected  	 VBN	O
from  	from  	 IN	O
an  	an  	 DT	O
electronic  	electronic  	 JJ	B-NP
database 	database 	 NN	I-NP
.  	.  	 .	O
According  	According  	 VBG	O
to  	to  	 TO	O
the  	the  	 DT	O
1-year  	1-year  	 JJ	O
mean  	mean  	 NN	B-NP
of  	of  	 IN	I-NP
25 	25 	 CD	I-NP
( 	( 	 -LRB-	I-NP
OH 	OH 	 NNP	I-NP
) 	) 	 -RRB-	I-NP
D  	D  	 NNP	I-NP
levels 	levels 	 NNS	O
,  	,  	 ,	O
75  	75  	 CD	O
recipients  	recipients  	 NNS	O
( 	( 	 -LRB-	O
22.7 	22.7 	 NNP	O
% 	% 	 NN	O
)  	)  	 -RRB-	O
had  	had  	 VBD	O
a  	a  	 DT	O
normal  	normal  	 JJ	B-NP
vitamin  	vitamin  	 JJ	I-NP
D  	D  	 NNP	I-NP
status 	status 	 NN	O
,  	,  	 ,	O
161  	161  	 CD	O
( 	( 	 -LRB-	O
48.6 	48.6 	 CD	O
% 	% 	 NN	O
)  	)  	 -RRB-	O
had  	had  	 VBD	O
insufficiency  	insufficiency  	 JJ	O
and  	and  	 CC	O
95  	95  	 CD	O
( 	( 	 -LRB-	O
28.7 	28.7 	 CD	O
% 	% 	 NN	O
)  	)  	 -RRB-	O
had  	had  	 VBD	O
deficiency  	deficiency  	 NN	O
in  	in  	 IN	O
vitamin  	vitamin  	 JJ	O
D  	D  	 NNP	O
levels 	levels 	 NNS	O
.  	.  	 .	O
During  	During  	 IN	O
the  	the  	 DT	O
follow-up 	follow-up 	 JJ	O
,  	,  	 ,	O
80  	80  	 CD	O
recipients  	recipients  	 NNS	O
presented  	presented  	 VBN	O
at  	at  	 IN	O
least  	least  	 JJS	O
one  	one  	 CD	O
cardiovascular  	cardiovascular  	 JJ	B-NP
event 	event 	 NN	I-NP
.  	.  	 .	O
The  	The  	 DT	O
total  	total  	 JJ	B-NP
cardiovascular  	cardiovascular  	 JJ	I-NP
diseases  	diseases  	 NNS	I-NP
included 	included 	 VBD	O
:  	:  	 :	O
27  	27  	 CD	O
patients  	patients  	 NNS	O
with  	with  	 IN	O
coronary  	coronary  	 JJ	B-NP
diseases 	diseases 	 NNS	I-NP
,  	,  	 ,	O
25  	25  	 CD	O
with  	with  	 IN	O
cardiac  	cardiac  	 JJ	B-NP
failure 	failure 	 NN	I-NP
,  	,  	 ,	O
18  	18  	 CD	O
with  	with  	 IN	O
arrhythmia 	arrhythmia 	 NN	B-NP
,  	,  	 ,	O
11  	11  	 CD	O
with  	with  	 IN	O
acute  	acute  	 JJ	O
cerebrovascular  	cerebrovascular  	 JJ	B-NP
events  	events  	 NNS	I-NP
and  	and  	 CC	O
19  	19  	 CD	O
with  	with  	 IN	O
peripheral  	peripheral  	 JJ	B-NP
vascular  	vascular  	 JJ	I-NP
disease 	disease 	 NN	I-NP
.  	.  	 .	O
Cardiovascular  	Cardiovascular  	 JJ	B-NP
events  	events  	 NNS	I-NP
were  	were  	 VBD	O
not  	not  	 RB	O
associated  	associated  	 VBN	O
with  	with  	 IN	O
25 	25 	 CD	B-NP
( 	( 	 -LRB-	I-NP
OH 	OH 	 NNP	I-NP
) 	) 	 -RRB-	I-NP
D  	D  	 NNP	I-NP
levels  	levels  	 NNS	O
or  	or  	 CC	O
vitamin  	vitamin  	 JJ	O
D  	D  	 NNP	O
status 	status 	 NN	O
,  	,  	 ,	O
and  	and  	 CC	O
the  	the  	 DT	O
10-year  	10-year  	 JJ	O
cumulative  	cumulative  	 JJ	B-NP
incidence  	incidence  	 NN	I-NP
was  	was  	 VBD	O
29.3 	29.3 	 CD	O
%  	%  	 NN	O
for  	for  	 IN	O
normal  	normal  	 JJ	B-NP
vitamin  	vitamin  	 JJ	I-NP
D  	D  	 NNP	I-NP
status  	status  	 NN	O
and  	and  	 CC	O
31.6 	31.6 	 CD	O
%  	%  	 NN	O
for  	for  	 IN	O
insufficiency  	insufficiency  	 NN	O
and  	and  	 CC	O
51.9 	51.9 	 CD	O
%  	%  	 NN	O
for  	for  	 IN	O
deficiency  	deficiency  	 NN	O
( 	( 	 -LRB-	O
P  	P  	 NN	O
=  	=  	 SYM	O
0.216 	0.216 	 CD	O
) 	) 	 -RRB-	O
.  	.  	 .	O
Furthermore 	Furthermore 	 RB	O
,  	,  	 ,	O
Cox  	Cox  	 NNP	B-NP
univariate  	univariate  	 JJ	I-NP
analysis  	analysis  	 NN	I-NP
showed  	showed  	 VBD	O
no  	no  	 DT	O
association  	association  	 NN	O
between  	between  	 IN	O
cardiovascular  	cardiovascular  	 JJ	B-NP
events  	events  	 NNS	I-NP
and  	and  	 CC	O
vitamin  	vitamin  	 JJ	O
D  	D  	 NNP	O
levels  	levels  	 NNS	O
or  	or  	 CC	O
vitamin  	vitamin  	 JJ	O
D  	D  	 NNP	O
status 	status 	 NN	O
.  	.  	 .	O
In  	In  	 IN	O
addition 	addition 	 NN	B-NP
,  	,  	 ,	O
53  	53  	 CD	O
recipients  	recipients  	 NNS	O
presented  	presented  	 VBN	O
at  	at  	 IN	O
least  	least  	 JJS	O
one  	one  	 CD	O
malignancy 	malignancy 	 NN	B-NP
:  	:  	 :	O
33  	33  	 CD	O
non-melanoma  	non-melanoma  	 JJ	B-NP
skin  	skin  	 NN	I-NP
malignancies  	malignancies  	 NNS	I-NP
and  	and  	 CC	O
20  	20  	 CD	O
non-skin  	non-skin  	 JJ	B-NP
malignancies  	malignancies  	 NNS	I-NP
( 	( 	 -LRB-	O
5  	5  	 CD	O
prostate 	prostate 	 NN	B-NP
,  	,  	 ,	O
3  	3  	 CD	O
kidney  	kidney  	 NN	O
and  	and  	 CC	O
urinary  	urinary  	 JJ	B-NP
tract 	tract 	 NN	I-NP
,  	,  	 ,	O
2  	2  	 CD	O
colon 	colon 	 NN	O
,  	,  	 ,	O
2  	2  	 CD	O
lung 	lung 	 NN	O
,  	,  	 ,	O
2  	2  	 CD	O
lymphoma 	lymphoma 	 NN	B-NP
,  	,  	 ,	O
2  	2  	 CD	O
breast  	breast  	 NN	O
and  	and  	 CC	O
4  	4  	 CD	O
from  	from  	 IN	O
other  	other  	 JJ	O
locations 	locations 	 NNS	O
) 	) 	 -RRB-	O
.  	.  	 .	O
The  	The  	 DT	O
cumulative  	cumulative  	 JJ	B-NP
incidence  	incidence  	 NN	I-NP
of  	of  	 IN	O
malignancies  	malignancies  	 NN	O
was  	was  	 VBD	O
21.3 	21.3 	 CD	O
%  	%  	 NN	O
for  	for  	 IN	O
normal  	normal  	 JJ	B-NP
vitamin  	vitamin  	 JJ	I-NP
D  	D  	 NNP	I-NP
status 	status 	 NN	O
,  	,  	 ,	O
22.7 	22.7 	 CD	O
%  	%  	 NN	O
for  	for  	 IN	O
insufficiency  	insufficiency  	 NN	O
and  	and  	 CC	O
16.7 	16.7 	 CD	O
%  	%  	 NN	O
for  	for  	 IN	O
deficiency  	deficiency  	 NN	O
( 	( 	 -LRB-	O
P  	P  	 NN	O
=  	=  	 SYM	O
0.818 	0.818 	 CD	O
) 	) 	 -RRB-	O
.  	.  	 .	O
Our  	Our  	 PRP$	O
data  	data  	 NNS	O
suggested  	suggested  	 VBD	O
that  	that  	 DT	O
low  	low  	 JJ	O
vitamin  	vitamin  	 JJ	O
D  	D  	 NNP	O
levels  	levels  	 NNS	O
were  	were  	 VBD	O
not  	not  	 RB	O
associated  	associated  	 VBN	O
with  	with  	 IN	O
an  	an  	 DT	O
increased  	increased  	 JJ	O
risk  	risk  	 NN	O
of  	of  	 IN	O
cardiovascular  	cardiovascular  	 JJ	B-NP
diseases  	diseases  	 NNS	I-NP
or  	or  	 CC	O
malignancies 	malignancies 	 NN	O
.  	.  	 .	O
However 	However 	 RB	O
,  	,  	 ,	O
due  	due  	 JJ	O
to  	to  	 TO	O
the  	the  	 DT	O
small  	small  	 JJ	O
number  	number  	 NN	O
of  	of  	 IN	O
patients  	patients  	 NNS	O
and  	and  	 CC	O
events 	events 	 NNS	O
,  	,  	 ,	O
the  	the  	 DT	O
results  	results  	 NNS	O
should  	should  	 MD	O
not  	not  	 RB	O
be  	be  	 VB	O
considered  	considered  	 VBN	O
as  	as  	 IN	O
definitive 	definitive 	 JJ	O
.  	.  	 .	O
Additional  	Additional  	 JJ	B-NP
studies  	studies  	 NNS	I-NP
with  	with  	 IN	O
a  	a  	 DT	O
higher  	higher  	 JJR	O
number  	number  	 NN	O
of  	of  	 IN	O
patients  	patients  	 NNS	O
are  	are  	 VBP	O
required  	required  	 VBN	O
to  	to  	 TO	O
elucidate  	elucidate  	 VB	O
the  	the  	 DT	O
true  	true  	 JJ	O
impact  	impact  	 NN	O
of  	of  	 IN	O
vitamin  	vitamin  	 JJ	O
D  	D  	 NNP	O
status  	status  	 NN	O
on  	on  	 IN	O
cardiovascular  	cardiovascular  	 JJ	O
and  	and  	 CC	O
malignancy  	malignancy  	 JJ	B-NP
risks 	risks 	 NNS	I-NP
.  	.  	 .	O
